Catalyst Wire Dossier Catalyst Wire Dossier

Cordyceps Sinensis Mycelium Culture Extract (CBG-CS-2)

Cordyceps sinensis mycelium culture extract
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cordyceps Sinensis Mycelium Culture Extract (CBG-CS-2), covering 2016-06-28 to 2016-06-28. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity [Phase 2, Phase 3]

See pricing